Emergency Department-Based COVID-19 Vaccination: Where Do We Stand?

Cautious optimism suggests the COVID-19 pandemic in the United States (U.S.) has reached a turning point. Cases have declined precipitously from their heights in the early winter months and vaccine distribution and administration has moved ahead at an accelerated pace. As of late-March, more than 140 million doses of COVID-19 vaccine had been administered in the U.S., with more than 27% of the population receiving at least one dose.1 Nevertheless, challenges with COVID-19 remain. Rates are increasing in select parts of the country, as non-pharmaceutical interventions such as mask mandates and capacity limits are relaxed; more transmissible variants now represent a greater proportion of new cases; and, vaccine hesitancy persists in many sectors of the population. With this shifting landscape, it is imperative that the U.S. continue to rapidly vaccinate as many individuals as possible. This article is protected by copyright. All rights reserved.